United Australia Party Senator Ralph Babet recently made an announcement on social media that his vaccine indemnity bill has passed the first stage of debate in the Senate. The bill proposes to remove vaccine indemnity from manufacturers, thereby shifting the responsibility for any vaccine-related issues from the government to the pharmaceutical companies themselves.
In his social media post, Senator Babet stated, “The best way to hold big pharma to account is to go after their profits. If this bill passes, it will result in safer products.” He believes that holding pharmaceutical companies accountable for any harm caused by their vaccines is common sense.
According to the current system, if something goes wrong with a vaccine, the government is responsible for any financial consequences. However, Senator Babet argues that it is only fair for the manufacturers to be held liable. Under the proposed legislation, pharmaceutical companies would be accountable if their vaccines cause harm.
During an interview, Senator Babet expressed his belief that this bill would reveal which members of Parliament prioritize the interests of the people over those of Big Pharma. He also expressed optimism about the bill’s chances of passing, stating that the voting process would show “who genuinely cares for Australians’ welfare.”
When asked about concerns that removing indemnity could lead major pharmaceutical companies like Pfizer to stop selling their products in Australia, Senator Babet drew a comparison to car manufacturers. He emphasized that if a car is faulty, the manufacturer should be responsible, which encourages them to invest in safer products. He believes that reputable pharmaceutical companies like Pfizer, Moderna, and AstraZeneca would continue to sell their products in Australia if they are safe and effective.
According to Senator Babet, indemnity is a recent concept that primarily serves the interests of big pharmaceutical companies. He stated that these companies’ main priority is making money, and if they produce safe and effective products, there should be no cause for concern.
If the bill is passed, it could mark a significant shift in how pharmaceutical companies operate in Australia. They would be held directly accountable for the safety and quality of their products, potentially leading to improved safety standards.
The debate surrounding this issue continues, with many people eagerly waiting to see how Parliament will respond.
Source link
